Drawing for PROTHYA BIOSOLUTIONS

USPTO serial 79338756

PROTHYA BIOSOLUTIONS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BLAKESLEE, RICHARD A
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PROTHYA BIOSOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

THOMAS J. MANGO

THOMAS J. MANGO CANTOR COLBURN LLP20 CHURCH STREET, 22ND FLOORHARTFORD, CT 06103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Blood plasma, whole blood, blood products and components in the nature of blood plasma for medical purposes; blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, human blood plasma, fractionated human blood plasma, all for medical useABANDONED—
035Advertising services; advertising and promotional services for others relating in particular to blood plasma, blood, blood products and components in the nature of blood plasma, blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, globular proteins, human blood plasma, fractionated human blood plasma, all for medical use and blood bank services, medical laboratory services, blood-supply organization services, namely, the collection and testing of blood, the development, preparation and testing of blood products, blood intermediate products, blood components, blood samples, plasma and plasma products; consultancy and advisory services relating to business management for blood banks and blood-supply organizations; business assistance with the management of commercial affairs; wholesale and retail store services relating to blood plasma, blood, blood products and components in the nature of blood plasma, blood intermediate products in the nature of blood plasma, and plasma products in the nature of Intravenous immunoglobulin (IVIG), human prothrombin complex, globular proteins, human blood plasma, fractionated human blood plasma, all for medical use; import-export agency services; promoting public awareness of the need for blood donations by recruiting blood donors for others; all aforementioned services also provided via the internetABANDONED—
044Blood bank services; medical laboratory services, relating to the preparation and maintenance of tissues, blood plasma and related products; blood-supply organization services, namely, the collection and testing of blood, the development, preparation and testing of blood products, blood intermediate products, blood components, blood samples, plasma and plasma products; consultancy and advisory services relating to blood banks and blood-supply organizations; all the foregoing services also being provided via the internetABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 11, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 11, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 9, 2025RFNPREFUSAL PROCESSED BY IB—
Mar 11, 2025MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Mar 11, 2025ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 11, 2025OP.TOPPOSITION TERMINATED NO. 999999—
Mar 11, 2025OP.SOPPOSITION SUSTAINED NO. 999999—
Mar 7, 2025OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Jun 13, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 13, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 10, 2024OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jun 4, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 4, 2024OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Dec 21, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2023GPNXNOTIFICATION PROCESSED BY IB—
Nov 15, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 15, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 18, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 16, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 27, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 12, 2023RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Sep 12, 2023RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Sep 12, 2023RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Aug 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 10, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 10, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 22, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 22, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 18, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 17, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2022RFNTREFUSAL PROCESSED BY IB—
Oct 17, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 17, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 24, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2022RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jul 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2022DOCKASSIGNED TO EXAMINER—
Jul 11, 2022LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
May 3, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance